De novo
Membranous Nephropathy in Renal Allografts is Associated With Protocadherin FAT1
Kidney Int Rep
.
2024 Oct 21;10(1):247-251.
doi: 10.1016/j.ekir.2024.10.012.
eCollection 2025 Jan.
Authors
Laith F Al-Rabadi
1
,
Aaron Storey
2
,
Christopher P Larsen
2
,
Samar I Hassen
2
,
Monica Patricia Revelo
3
,
Ravi Shankar Singh
3
,
Eszter Lazar-Molnar
3
,
Dharmendra Jain
3
,
Abdelrahman Ibrahim
1
,
Frank Darras
4
,
Rania Salam
5
,
Ala Al-Rabadi
6
,
Naruemon Wikan
1
,
Vanessa Redecke
3
,
Manish Talwar
7
,
Hans Haecker
3
,
Laurence H Beck Jr
8
,
Tiffany N Caza
2
Affiliations
1
Renal Division, University of Utah, Salt Lake City, Utah, USA.
2
Arkana Laboratories, Little Rock, Arkansas, USA.
3
Department of Pathology, University of Utah, Salt Lake City, Utah, USA.
4
Department of Urology, State University of New York at Stony Brook, Stony Brook, New York, USA.
5
Renal Division, State University of New York at Stony Brook, Stony Brook, New York, USA.
6
Internal Medicine Department, Jordan University of Science and Technology, Bani Obeid, Jordan.
7
Methodist Transplant Institute, Memphis, Tennessee, USA.
8
Division of Nephrology, Boston Medical Center, Boston, Massachusetts, USA.
PMID:
39810776
PMCID:
PMC11725789
DOI:
10.1016/j.ekir.2024.10.012
No abstract available
Keywords:
FAT1; de novo membranous nephropathy; donor-specific antibodies; kidney biopsy.